It uses a variety of algorithms, 10 distinct modules and more than 230 million big data entries. “Our Chemiverse platform is allowing us to expedite the long R&D cycles common in drug discovery ...

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

“The utilization of AI and big data is revolutionizing our drug-discovery process. What once required many years and enormous costs is now being significantly streamlined with the aid of AI ...

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

Finding new medicines has always been a long, expensive, and complicated process. Scientists need to identify the right targets in the body, test thousands of potential compounds, and spend years in ...

Chip maker AMD is investing $20 million in AI drug startup Absci, which will use AMD chips and software for drug development.

The deal expands a deal to discover and develop treatments for obesity, type 2 diabetes and cardiovascular disease using ...

Recursion’s innovative drug discovery process integrates dry lab (experiments run in-silico), wet lab (traditional experiments), AI-powered data analysis, and LOWE (LLM-orchestrated Workflow ...

(THE CONVERSATION) The potential of using artificial intelligence in drug discovery and development has sparked both ... in the drug development process when provided with high-quality data and ...

Focus will be given to the latest advances in small molecule drug discovery and development, biopharma and biotechnology. This online symposium will explore: Leveraging AI for transformative drug ...

In recent years, generative AI (GenAI) has become a prominent topic of discussion in life sciences. However, I often hear from my life science clients about the need for more clarity around its ...

The $20 million deal gives the chip supplier a toehold in the life-sciences market, a strategy it plans to replicate in other ...